Clinical Trial

Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research

Recruiting
View on ClinicalTrials.gov →
Summary
The China Alliance for Type 1 Diabetes (CAT1D) is committed to exploring and implementing the model of graded diagnosis and treatment of type 1 diabetes and comprehensive management of outpatient service, carrying out a series of educational activities for patients, and cooperating in the development of multi-center prospective clinical research on type 1 diabetes.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-09-17; most recent amendment 2023-04-19.
Trial Details
NCT Number NCT04096794
Lead Sponsor Second Xiangya Hospital of Central South University
Conditions Type 1 Diabetes Mellitus
Enrollment 500 participants
Start Date 2016-09
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2023-04-21